Accelerator Corp. is a Seattle-based venture capital firm founded in 2003 that specializes in early-stage biotechnology investments. See contact routes.
Accelerator Corp. is a Seattle-based venture capital firm founded in 2003 that specializes in early-stage biotechnology investments, typically deploying up to $2 million per company in seed or Series A rounds. The firm’s distinctive thesis focuses on catalyzing the development and commercialization of breakthrough life sciences innovations by providing not just capital but also access to state-of-the-art facilities and scientific expertise through partnerships with top-tier research institutions. Notable portfolio companies include Petra Pharma (which raised a $48 million Series A), Lodo Therapeutics (backed by the Gates Foundation), Oncofactor, Groove Biopharma, and Theraclone Sciences, with one portfolio exit via the sale of the XORI antibody platform. Accelerator does not participate in subsequent financing rounds and typically holds investments for 12–24 months, having invested in nine companies over the past five years, three of which secured follow-on funding exceeding $114 million.
Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist comparable investors.
Investors like Accelerator Corp. · Full investor directory · Investor access · Company funding database